Este estudio, basado en técnicas de proteómica avanzada, evidencia nuevos beneficios para la salud de un extracto de compuestos fenólicos del AOVE.
Read moreLos hombres portadores de variantes patogénicas en los genes BRCA1 y BRCA2 tienen un riesgo elevado de cáncer de próstata, páncreas y mama.
Read moreDespués de cinco años de seguimiento del estudio NADIM, el estudio constata la robustez de esta nueva estrategia que pasa por administrar quimioinmunoterapia antes de la cirugía en este grupo de pa...
Read moreUn equipo del IMIBIC y de la Universidad de Córdoba prueba el efecto protector de un extracto de ajo negro fermentado contra la inflamación y la progresión del cáncer de próstata en un estudio re...
Read moreIBEC principal investigator Zaida Álvarez has received funding from the US National Institutes of Health (NIH) to develop stem cell-based models of the spinal cord.
Read moreTras el reciente fallecimiento de Sammy Basso, el enfermo de progeria más longevo, el investigador Ignacio Benedicto, del CIB-CSIC, explica las causas y tratamientos de esta enfermedad rara que provo...
Read moreResearchers from IBEC and ICFO demonstrate the ability of atomic sensors to non-destructively monitor, measure and optimize nuclear spin hyperpolarization of some clinically relevant molecules in real...
Read moreIt has been demonstrated the possibility to bond indane-based monomers in an extremely selective and efficient way, for fabricating π-conjugated polymers on a surface that host intrinsic solitons
Read moreThis funding is intended to prepare CRISPR-Cas technology to reach the market, and to provide the basis for rapid and reliable genetic testing available to users.
Read moreResearchers from the ibs.GRANADA and the UGR have developed a new nanodrug using magnetic particles specifically designed to combat colon cancer
Read moreThe scientific team has identified, in this group of people, the CCR5Δ32 genetic mutation, which protects against HIV, as well as an atypical immune response with lower activation and reduced levels ...
Read moreThe ADAPTMET consortium comprises 14 institutions, including several of the leading academic, clinical, and industrial organisations in cancer and metastasis research across Europe.
Read more